HIV fusion inhibitors (Wuhan University)

N/A

Report date: 2025/01/26 19:01:34

Base Information

Drug NameHIV fusion inhibitors (Wuhan University)
Drug Alias Namegossypol derivatives (Wuhan University)HIV gp41 protein inhibitor (Wuhan University)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTransmembrane glycoprotein gp41 inhibitors
TargetsTransmembrane glycoprotein gp41
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWuhan University
China Registration ClassN/A

Develop Information

Active CompaniesWuhan University
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A